jueves, 14 de diciembre de 2023

Human Drug Compounding: FDA issues draft guidance documents that would end to categorization of bulk substances newly nominated for the 503A and 503B bulks lists

https://www.fda.gov/drugs/guidance-compliance-regulatory-information/human-drug-compounding?utm_medium=email&utm_source=govdelivery

No hay comentarios: